Minimally invasive endoscopic aortic valve replacement for alkaptonuria-associated severe aortic stenosis: a case report and literature review

2020 ◽  
Author(s):  
Shinichiro Taniguchi ◽  
Takashi Shimada ◽  
Tatsuya Miyanaga
Keyword(s):  
Case Report ◽  
Aortic Valve ◽  
Literature Review ◽  
Aortic Stenosis ◽  
Aortic Valve Replacement ◽  
Minimally Invasive ◽  
Valve Replacement ◽  
Severe Aortic Stenosis

scholarly journals Simultaneous Aortic Valve Replacement with Nephrectomy: A Case Report

2018 ◽  
Vol 02 (02) ◽  
pp. 098-101
Author(s):  
Ajmer Singh ◽  
Aashish Jain ◽  
Yatin Mehta ◽  
Naresh Trehan
Keyword(s):  
Case Report ◽  
Aortic Valve ◽  
Aortic Stenosis ◽  
Aortic Valve Replacement ◽  
Valve Replacement ◽  
Renal Mass ◽  
Severe Aortic Stenosis ◽  
Simultaneous Surgery ◽  
Life Threatening ◽  
Potential Benefits

AbstractA 60-year-old man presented to the authors’ institution and underwent simultaneous surgery for severe aortic stenosis and left renal mass. Potential benefits of a combined cardiac and noncardiac procedure are discussed. The literature, however, is scarce on standards of management of patients with two coexisting life-threatening conditions.

scholarly journals Aortic valve function post-replacement of severe aortic stenosis by transcatheter procedure versus surgery: a systematic review and metanalysis

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Charbel Abi Khalil ◽  
Barbara Ignatiuk ◽  
Guliz Erdem ◽  
Hiam Chemaitelly ◽  
Fabio Barilli ◽  
...  
Keyword(s):  
Aortic Valve ◽  
Aortic Stenosis ◽  
Aortic Valve Replacement ◽  
Valve Replacement ◽  
Randomized Clinical Trials ◽  
Severe Aortic Stenosis ◽  
Paravalvular Leak ◽  
Effective Orifice Area ◽  
Surgical Aortic Valve Replacement ◽  
Transcatheter Heart Valve

AbstractTranscatheter aortic valve replacement (TAVR) has shown to reduce mortality compared to surgical aortic valve replacement (sAVR). However, it is unknown which procedure is associated with better post-procedural valvular function. We conducted a meta-analysis of randomized clinical trials that compared TAVR to sAVR for at least 2 years. The primary outcome was post-procedural patient-prosthesis-mismatch (PPM). Secondary outcomes were post-procedural and 2-year: effective orifice area (EOA), paravalvular gradient (PVG) and moderate/severe paravalvular leak (PVL). We identified 6 trials with a total of 7022 participants with severe aortic stenosis. TAVR was associated with 37% (95% CI [0.51–0.78) mean RR reduction of post-procedural PPM, a decrease that was not affected by the surgical risk at inclusion, neither by the transcatheter heart valve system. Postprocedural changes in gradient and EOA were also in favor of TAVR as there was a pooled mean difference decrease of 0.56 (95% CI [0.73–0.38]) in gradient and an increase of 0.47 (95% CI [0.38–0.56]) in EOA. Additionally, self-expandable valves were associated with a higher decrease in gradient than balloon ones (beta = 0.38; 95% CI [0.12–0.64]). However, TAVR was associated with a higher risk of moderate/severe PVL (pooled RR: 9.54, 95% CI [5.53–16.46]). All results were sustainable at 2 years.

Sign in / Sign up

Export Citation Format

Share Document